• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd

Merck KGaA

Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands
Pharma

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

With Kai Beckmann now at the helm of Merck KGaA, the CEO is making his mark with a big outlay to support the German conglomerate’s life science arm.
Fraiser Kansteiner Jun 25, 2026 9:56am
Merck of Germany

Merck KGaA's new CEO Beckmann emphasizes reliance on M&A

May 13, 2026 11:54am
drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am
Illustration of multiple orange alarm clocks floating against a blue background scattered at different angles as if suspende

The top 10 drugs losing US exclusivity in 2026

Mar 16, 2026 3:00am
Asia

Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia

Mar 13, 2026 8:05am
Merck of Germany

Merck KGaA expects Mavenclad generics to deal serious blow in US

Mar 5, 2026 11:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings